Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 20.59 USD 0.49% Market Closed
Market Cap: 1.5B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Cash Flow Statement

Cash Flow Statement
Kiniksa Pharmaceuticals Ltd

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Operating Cash Flow
Net Income
(65)
(76)
(85)
(93)
(103)
(153)
(170)
(173)
(162)
(122)
(123)
(140)
(161)
(184)
(189)
(175)
(158)
(134)
(112)
143
183
196
231
(7)
14
9
(10)
Depreciation & Amortization
0
0
0
0
0
1
1
2
2
2
2
2
2
2
2
2
2
3
3
2
2
2
2
2
2
2
2
Change in Deffered Taxes
(0)
(0)
(1)
(1)
(1)
(1)
(2)
(3)
(3)
(4)
3
5
4
5
(0)
0
0
0
0
(186)
(186)
(184)
(204)
(8)
(34)
(31)
(0)
Stock-Based Compensation
1
1
3
4
6
8
10
13
15
16
18
20
21
24
25
25
25
24
25
25
25
25
25
26
27
28
29
Other Non-Cash Items
1
1
3
3
5
13
16
18
22
17
18
21
22
26
28
29
29
27
28
28
28
27
26
28
29
32
33
Cash Taxes Paid
0
0
0
1
0
0
1
2
2
2
1
0
0
0
1
1
1
0
4
5
11
14
14
13
6
2
0
Change in Working Capital
14
15
16
14
18
11
2
(5)
(17)
(20)
(14)
(8)
(4)
6
4
(4)
1
(19)
(11)
11
(23)
(3)
(13)
(19)
1
10
6
Cash from Operating Activities
(50)
N/A
(60)
-18%
(67)
-13%
(77)
-14%
(81)
-6%
(129)
-60%
(153)
-18%
(162)
-6%
(158)
+2%
(127)
+20%
(114)
+10%
(120)
-4%
(137)
-14%
(145)
-6%
(154)
-7%
(149)
+4%
(126)
+15%
(123)
+3%
(92)
+25%
(2)
+98%
6
N/A
38
+561%
42
+11%
(3)
N/A
13
N/A
22
+62%
30
+41%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
(1)
(5)
(7)
(6)
(5)
(3)
(2)
(3)
(2)
(0)
(20)
(20)
(20)
(20)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Items
0
0
(74)
(268)
(234)
(242)
(127)
82
52
149
77
(88)
(23)
(47)
70
268
149
61
14
(15)
(8)
(23)
(26)
(57)
(29)
34
(48)
Cash from Investing Activities
(0)
N/A
(0)
-86%
(74)
-56 838%
(269)
-263%
(239)
+11%
(248)
-4%
(133)
+46%
77
N/A
49
-36%
147
+199%
75
-49%
(90)
N/A
(23)
+74%
(67)
-188%
50
N/A
247
+396%
129
-48%
61
-53%
13
-78%
(15)
N/A
(8)
+48%
(23)
-188%
(26)
-12%
(57)
-120%
(30)
+48%
34
N/A
(48)
N/A
Financing Cash Flow
Net Issuance of Common Stock
40
191
350
350
350
243
84
84
84
3
81
228
228
227
150
6
6
5
5
3
3
2
2
2
4
8
9
Other
0
(0)
(3)
(4)
(4)
(4)
(1)
(0)
(0)
(0)
(1)
(1)
(1)
0
(1)
(0)
0
0
0
0
0
0
0
0
(2)
(3)
(4)
Cash from Financing Activities
40
N/A
191
+379%
347
+82%
346
0%
347
+0%
239
-31%
83
-65%
84
+1%
84
+0%
3
-96%
80
+2 315%
227
+182%
227
+0%
226
-1%
149
-34%
5
-96%
6
+9%
5
-12%
5
-6%
3
-48%
3
-1%
2
-13%
2
-18%
2
+11%
1
-25%
5
+236%
5
-7%
Change in Cash
Net Change in Cash
(10)
N/A
131
N/A
206
+57%
1
-100%
27
+3 058%
(139)
N/A
(203)
-46%
(1)
+100%
(25)
-2 813%
24
N/A
41
+71%
17
-58%
67
+293%
14
-80%
45
+229%
104
+134%
8
-92%
(57)
N/A
(74)
-30%
(14)
+80%
0
N/A
17
+6 820%
18
+6%
(58)
N/A
(15)
+75%
60
N/A
(13)
N/A
Free Cash Flow
Free Cash Flow
(50)
N/A
(60)
-19%
(68)
-13%
(78)
-15%
(86)
-11%
(136)
-58%
(159)
-17%
(167)
-5%
(162)
+3%
(129)
+20%
(117)
+9%
(122)
-4%
(137)
-12%
(165)
-21%
(175)
-6%
(169)
+3%
(147)
+13%
(123)
+16%
(92)
+25%
(2)
+98%
6
N/A
38
+571%
42
+11%
(3)
N/A
13
N/A
21
+62%
30
+42%

See Also

Discover More